title: Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?
authors.forename: J F
authors.initials: JF
authors.lastname: Colombel
authors.forename: G
authors.initials: G
authors.lastname: Brabant
authors.forename: M C
authors.initials: MC
authors.lastname: Gubler
authors.forename: A
authors.initials: A
authors.lastname: Locquet
authors.forename: M C
authors.initials: MC
authors.lastname: Comes
authors.forename: M
authors.initials: M
authors.lastname: Dehennault
authors.forename: M
authors.initials: M
authors.lastname: Delcroix
mesh_terms: D000328:Adult; D000636:Aminosalicylic Acids / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000139:chemically induced / Q000151:congenital*; D008297:Male; D019804:Mesalamine; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
chemical_list: D000636:Aminosalicylic Acids; D019804:Mesalamine